Experts say low efficiency Chinese vaccines will reduce the achievement in diplomatic vaccine gamble.

"China has accepted risks when placing their vaccine diplomatic strategy in the position against the Vaccine policy bearing the color of nationalism which is being pursued by the US and many other countries," David P. Fidler

Risks that China accepted both related to the ability to meet the number of vaccines committed to support all over the world, both an effective story to prevent NCOV infection.

Experts in Chile have discovered Sinovac's first injection only to bring about 16% effective in preventing NCOV infection.

Thai medical staff vaccinated Covid-19 for people in Bangkok with Vaccine Sinovac on March 18.

Sinovac's severe vaccination ratio is much lower than that of Pfizer and Biontech vaccines.

Chile became a warning story for many countries like Brazil, Colombia, Turkey or Indonesia.

In a comment on Nikkei Asia, Professionals Yanzhong Huang and Samantha Kiernan of CFR note that Chinese vaccines are widely deployed in Chile and unified Arab Emirates (UAE) but NCOV infections still increase or

"With some countries who are fighting against more dangerous outbreaks or newly contagious strains, these skeptics are enough for them to stay away from Chinese vaccines, fading diplomatic results", specialties

David P. Fidler analyzes Beijing's strategic aimed at two basic goals: China wants to target the international community from political controversies about the first response measures when the new Covid-19 translation outbreaks in

"When pursuing political and geopolitical goals, China has not transparently on the safety and effectiveness of the vaccines used for diplomacy. Thus, China has accepted risks when actually

Teachers in the city of Santiago, Chile waiting for vaccines on February 15.

However, according to FIDLER, the vaccine was developed by China ineffectively developed by Western vaccines in general "not threatening global health security".

"Low efficient vaccines can reduce political results that China wants through diplomacy vaccines, but they can argue that: in crisis moment, China has made efforts to support vaccines for other countries, in

The United States has the potential to return to the race for domestic vaccines to progress quickly.

"Even so, even when diplomacy vaccines cannot promote the effectiveness of foreign policy benefits and China's global benefits, this outcome still does not affect their strength and influence in and